Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.
about
Divergent roles for tumor necrosis factor-alpha in the brainRole of berberine in Alzheimer's diseaseGlutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients.Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic AgentsInduction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease.Alzheimer vaccine: amyloid-beta on trial.Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenesThe microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor.Different Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90-231 Neurotoxic Effects in Cerebellar Granule Neurons.The Interplay of MicroRNAs in the Inflammatory Mechanisms Following Ischemic Stroke.Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells.Loss of tau rescues inflammation-mediated neurodegeneration.Recent developments in Alzheimer's disease.Changes in APP, PS1 and other factors related to Alzheimer's disease pathophysiology after trimethyltin-induced brain lesion in the rat.MicroRNA-181c negatively regulates the inflammatory response in oxygen-glucose-deprived microglia by targeting Toll-like receptor 4.Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease.
P2860
Q23916360-6F41A2CE-D2AA-4970-B18C-BB0D4774BADBQ28067321-797DE886-840D-46FF-9DFD-A59F492E0634Q30313120-4A583071-FA7C-487D-B75E-E69027A50FBAQ30315907-D012F08C-C365-46F1-BB8F-2209EC1EF074Q33223171-20018C9B-3228-470F-8149-DBF960F27CBAQ33783563-17831253-84E6-4C09-AF2B-314C326A3C40Q34291417-8CAFE64A-1B14-4D2B-9E7E-2D4BAD9DEC0AQ35069720-09BAE2D7-F085-4318-9CF8-7233FC4CFE8BQ35663346-296C2FA8-1BB7-4DAD-B21C-0E0841B9BD2AQ36369776-3BB75BE4-CF40-45FC-97E6-5C577BD7CC71Q38765903-B63C7284-F824-40E1-B982-96C390664D55Q39324614-2E8F23C3-1594-40AD-8146-0079A1734421Q40654925-CC5EB8FB-F06A-41C7-B63A-FE31F965D30DQ41590526-FB6F71A1-F160-4181-8870-BCE3551A46B5Q43841496-3618ECD0-966E-4C49-9E9C-0F442A8757CBQ48328269-1DEAAD6A-7F27-4E74-95EB-19D27DFEA748Q48397806-CAEE3826-7022-49EF-B850-5746EBA4CF6AQ48873897-F84CB5CF-2127-4FB6-BB3E-6534F8789808
P2860
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.
@ast
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.
@en
type
label
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.
@ast
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.
@en
prefLabel
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.
@ast
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.
@en
P2093
P1476
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications
@en
P2093
A J Rozemuller
P Eikelenboom
R Veerhuis
W A van Gool
P304
P356
10.1097/00002093-200000001-00009
P407
P478
14 Suppl 1
P577
2000-01-01T00:00:00Z